Barer Sol J insider trades
Barer Sol J has filed 21 Form 4s with the SEC that we hold, for NEXI (Director), Teva Pharmaceutical Industries LTD (TEVA) (Director) and CFRX (Director). Across all of them we count 10 purchases worth $712.5K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 400,000 shares of NEXI worth $164.0K, dated 2023-03-30. The first filing on our record is dated 2021-12-22 and the latest 2026-06-08.
NEXI
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-18 | P, purchase reported on Form 4 | 30,000 | $63.3K | 2022-03-21 |
| 2022-03-21 | P, purchase reported on Form 4 | 30,000 | $64.2K | 2022-03-22 |
| 2022-03-22 | P, purchase reported on Form 4 | 30,000 | $72.3K | 2022-03-23 |
| 2022-03-23 | P, purchase reported on Form 4 | 10,000 | $26.7K | 2022-03-24 |
| 2022-05-31 | P, purchase reported on Form 4 | 39,280 | $86.0K | 2022-06-02 |
| 2022-06-01 | P, purchase reported on Form 4 | 40,000 | $94.0K | 2022-06-02 |
| 2022-06-02 | P, purchase reported on Form 4 | 20,720 | $46.0K | 2022-06-02 |
| 2022-11-16 | P, purchase reported on Form 4 | 125,000 | $60.0K | 2022-11-17 |
| 2022-11-17 | P, purchase reported on Form 4 | 75,000 | $36.0K | 2022-11-17 |
| 2023-03-30 | P, purchase reported on Form 4 | 400,000 | $164.0K | 2023-03-31 |
Teva Pharmaceutical Industries LTD (TEVA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CFRX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1247015) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms